Skip to content

Clinical trials

Lung Diseases, Obstructive trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20161
20171
20181
20191
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Li Xuyan2
Capital Medical University1
China-Japan Friendship Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai University of Traditional Chinese Medicine1
Tang-Du Hospital1
The First Affiliated Hospital of Guangzhou Medical University1
snow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive11
Pulmonary Disease, Chronic Obstructive4
Asthma2
Lung Diseases2
Bronchial Diseases1
Respiratory Tract Diseases1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.